0001189724-16-000015.txt : 20160331 0001189724-16-000015.hdr.sgml : 20160331 20160331190333 ACCESSION NUMBER: 0001189724-16-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160331 DATE AS OF CHANGE: 20160331 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lamb Scott E CENTRAL INDEX KEY: 0001375852 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 161544531 MAIL ADDRESS: STREET 1: ICU MEDICAL, INC. STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-03-31 0 0000883984 ICU MEDICAL INC/DE ICUI 0001375852 Lamb Scott E 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Secretary, Treasurer, Common Stock 2016-03-31 4 X 0 15000.0 37.0 A 19381 D Common Stock 2016-03-31 4 S 0 15000.0 105.0 D 4381 D Common Stock 2016-03-31 4 X 0 15000.0 32.31 A 19381 D Common Stock 2016-03-31 4 S 0 15000.0 105.0 D 4381 D Common Stock 2016-03-31 4 X 0 14026.0 38.85 A 18407 D Common Stock 2016-03-31 4 S 0 14026.0 105.0 D 4381 D Non-Qualified Stock Option (right to buy) 32.31 2016-03-31 4 X 0 15000.0 32.31 D 2020-02-04 Common Stock 15000 0 D Non-Qualified Stock Option (right to buy) 37.0 2016-03-31 4 X 0 15000.0 37.0 D 2020-07-21 Common Stock 15000 0 D Non-Qualified Stock Option (right to buy) 38.85 2016-03-31 4 X 0 14026.0 38.85 D 2019-07-22 Common Stock 14026 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2015. Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Transaction is the exercise of a derivative security; see Column 2. By: Paula Darbyshire For: Scott E. Lamb 2016-03-31